 |
| | Suchergebnis | | | | | | | | | © | |
|
| | | |||||||||||||
|
 |
Suchgeschichte |  |
| |
|
Kurzliste | |
| |
|
Detailanzeige | |
|
|
|
|
|
|
|
|
||||||||||
|
|
|||||
______________ | ||||||
|
|
|
|||
|
1 - 3 von 3 |
| ||
 |
Ihre Aktion | Suchen (Schlagwörter GND (Phrase) (XSP)) impfstoff eingrenzen (Basisklassifikation (XBKL)) 58.28 |
||
| |
| |
| |
|
|
|
|
 |
1. |
U.S. markets for vaccines : characteristics, case studies, and controversies Berndt, Ernst R.. - Washington, DC : AEI Press, c 2009 |
|
| |||
|
2. |
Vaccine design : the role of cytokine networks : [proceedings of the 5th NATO Advanced Study Institute on Vaccine Design: The Role of Cytokine Networks, held June 24 - July 5, 1996, in Cape Sounion, Greece] Gregoriadis, Gregory. - New York, NY [u.a.] : Plenum Press, 1997 |
|
| |||
|
3. |
Zellkulturen - Forschung, medizinische Diagnostik, Impfstoffproduktion Nissen, Eberhard. - 1. Aufl. - Berlin : VEB Verlag Volk und Gesundheit, 1988 |
|
| |||
| |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
|
1 - 3 von 3 |
|
|
|
1 - 3 von 3 |
|
|||||||||||||||||||||||||